港龙风采
R & D Strength
Based on genome technology and biochip research, Genetel Pharmaceuticals (Shenzhen) Co., Ltd. is committed to developing a series of early diagnostic products and new therapeutic drugs with independent intellectual property rights, and to industrializing early diagnostic products and new drugs.
Genetel Pharmaceuticals (Shenzhen) Co., Ltd. has R&D department. R&D personnel are professionals with rich experience in biochemistry, genomics, biochip and other fields. Among them, 50% of R&D personnel have master's degree and doctor's degree.
Genetel Pharmaceuticals (Shenzhen) Co., Ltd. insists on independent development and innovation, and has owned a number of technologies and products with independent intellectual property rights. Up to now, 10 patents have been applied for and obtained for the developed biotechnologies and products, and many of them have the world's leading level.
Nucleic acid protein determinator-BioPhotometer Plus
Real-time fluorescence quantitative PCR system-LightCycler1.5
Real-time fluorescence quantitative PCR system-ABI7300
Real-time fluorescence quantitative PCR system-LightCycler480II
